ZIMLAB logo

ZIM Laboratories Limited

ZIMLAB·NSE·
119.40 +1.46 (+1.24%)
Market Cap706.85 Cr
PE Ratio109.54
Volume61,221
Day High - Low121.48 - 116.30
52W High-Low133.90 - 59.31
DocStoX Score
3.7/10
Poor
Fair Value
Sign in to see
ROE
1.59%
Weak
P/E
109.54x
Expensive
Debt / Equity
0.44
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day116.30
121.48
52W59.31
133.90
DocStoX take

Supported by risk (8.1) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 8.1, but that is offset by valuation at 0.0 and growth at 1.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
3.7
/10
Poor
Quality
Modest
ROE 1.6%
Valuation
Expensive
P/E 109.5×
Growth
Flat
Revenue +4.0% 5Y CAGR
Risk
Low risk
D/E 0.44
Momentum
Strong
81% of 52-week range

At a glance

Market Cap
₹707 Cr
52W High / Low
₹134 / ₹59
Dividend Yield
0.00%
Promoter Holding
30.36%
EPS (TTM)
₹1.09
Book Value
₹55.40

Key highlights

  • Profitable in all of the last 5 years
  • Profit shrinking 3% a year
  • Valuation is weak (0.0/10)
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

ZIM LABORATORIES LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.